Cargando…

Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab

OBJECTIVES: The mechanism of action of treatment with tumour necrosis factor (TNF) blockers in rheumatoid arthritis (RA) is still not completely understood. The aim of this study was to test if adalimumab treatment could affect the influx of monocytes into the synovium. METHODS: A novel technique wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herenius, M M J, Thurlings, R M, Wijbrandts, C A, Bennink, R J, Dohmen, S E, Voermans, C, Wouters, D, Izmailova, E S, Gerlag, D M, van Eck-Smit, B L F, Tak, P P
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Group 2011
Materias:	Basic and Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086080/ https://www.ncbi.nlm.nih.gov/pubmed/21345816 http://dx.doi.org/10.1136/ard.2010.141549

Ejemplares similares

Monocyte Scintigraphy in Rheumatoid Arthritis: The Dynamics of Monocyte Migration in Immune-Mediated Inflammatory Disease
por: Thurlings, Rogier M., et al.
Publicado: (2009)

Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss
por: Wijbrandts, C A, et al.
Publicado: (2008)

Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response
por: Thurlings, R M, et al.
Publicado: (2008)

Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared to 2010 ACR/EULAR criteria): a prospective study aimed at identification of diagnostic and prognostic biomarkers as well as therapeutic targets
por: de Launay, Daphne, et al.
Publicado: (2011)

Anti-TNF Therapy Reduces Serum Levels of Chemerin in Rheumatoid Arthritis: A New Mechanism by Which Anti-TNF Might Reduce Inflammation
por: Herenius, Marieke M. J., et al.
Publicado: (2013)

The cellular composition of lymph nodes in the earliest phase of inflammatory arthritis
por: van Baarsen, L G M, et al.
Publicado: (2013)

The Gene Expression Profile in the Synovium as a Predictor of the Clinical Response to Infliximab Treatment in Rheumatoid Arthritis
por: Lindberg, Johan, et al.
Publicado: (2010)

The Features of the Synovium in Early Rheumatoid Arthritis According to the 2010 ACR/EULAR Classification Criteria
por: van de Sande, Marleen G. H., et al.
Publicado: (2012)

Impact of Adalimumab Treatment on Interleukin-17 and Interleukin-17 Receptor Expression in Skin and Synovium of Psoriatic Arthritis Patients with Mild Psoriasis
por: Bolt, Janne W., et al.
Publicado: (2022)

Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis
por: Klaasen, R., et al.
Publicado: (2012)

Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis
por: Greven, D E A, et al.
Publicado: (2015)

Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis
por: Tak, Paul P, et al.
Publicado: (2017)

Functional Tissue Analysis Reveals Successful Cryopreservation of Human Osteoarthritic Synovium
por: Broeren, Mathijs G. A., et al.
Publicado: (2016)

The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation
por: Tang, Man Wai, et al.
Publicado: (2016)

TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade
por: van Kuijk, A W R, et al.
Publicado: (2009)

Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors
por: Ciechomska, Marzena, et al.
Publicado: (2013)

Non-classical monocytes as mediators of tissue destruction in arthritis
por: Puchner, Antonia, et al.
Publicado: (2018)

Monocyte Siglec-14 expression is upregulated in patients with systemic lupus erythematosus and correlates with lupus disease activity
por: Thornhill, Susannah I., et al.
Publicado: (2017)

Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint
por: Smiljanovic, Biljana, et al.
Publicado: (2018)

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium
por: Wijbrandts, C A, et al.
Publicado: (2008)

Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay
por: Grabiec, Aleksander M, et al.
Publicado: (2011)

Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment
por: Lebre, Maria C, et al.
Publicado: (2012)

HOXA5 is a key regulator of class 3 semaphorins expression in the synovium of rheumatoid arthritis patients
por: Martínez-Ramos, Sara, et al.
Publicado: (2022)

The rs1143679 (R77H) lupus associated variant of ITGAM (CD11b) impairs complement receptor 3 mediated functions in human monocytes
por: Rhodes, Benjamin, et al.
Publicado: (2012)

Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss
por: Kaur, K, et al.
Publicado: (2009)

Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases
por: Hinks, A, et al.
Publicado: (2017)

Modulation of Inflamed Synovium Improves Migration of Mesenchymal Stromal Cells in Vitro Through Anti-Inflammatory Macrophages
por: Wesdorp, Marinus A., et al.
Publicado: (2022)

Features of the Synovium of Individuals at Risk of Developing Rheumatoid Arthritis: Implications for Understanding Preclinical Rheumatoid Arthritis
por: de Hair, MJH, et al.
Publicado: (2014)

Role of vascular channels as a novel mechanism for subchondral bone damage at cruciate ligament entheses in osteoarthritis and inflammatory arthritis
por: Binks, D A, et al.
Publicado: (2015)

TLR1/2 and 5 induce elevated cytokine levels from rheumatoid arthritis monocytes independent of ACPA or RF autoantibody status
por: Thwaites, Ryan S, et al.
Publicado: (2020)

Tissue-resident, extravascular Ly6c(−) monocytes are critical for inflammation in the synovium
por: Montgomery, Anna B., et al.
Publicado: (2023)

Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis
por: Wijbrandts, C A, et al.
Publicado: (2008)

Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression
por: Ross, E A, et al.
Publicado: (2017)

T cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals
por: Hunt, L, et al.
Publicado: (2016)

Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
por: Bell, G M, et al.
Publicado: (2017)

Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes
por: Angiolilli, Chiara, et al.
Publicado: (2017)

Thymic function in juvenile idiopathic arthritis
por: Lorenzi, A R, et al.
Publicado: (2008)

Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model
por: LaBranche, Timothy P, et al.
Publicado: (2017)

Ankylosing spondylitis is associated with the anthrax toxin receptor 2 gene (ANTXR2)
por: Karaderi, T, et al.
Publicado: (2014)

Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study
por: Panoutsopoulou, K, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_m6dj9q4p0ig01ch4b74pbq6oor